Skip to main content

Table 2 Response Rates to NC incorporating trastuzumab

From: Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients

 

N

PD

cPR

cCR

tpCR

bpCR

Total

46 (100%)

2 (4.4%)

23 (50%)

21 (45.6%)

23 (50%)

26 (56.5%)

ER status

      

Positive

22 (47.8%)

 

13 (59%)

9 (41%)

10 (45.4%)

12 (54.5%)

Negative

24 (52.2%)

2 (8.3%)

10 (41.7%)

12 (50%)

13 (54.2%)

14 (58.3%)

Stage distribution

      

IIA

6 (13%)

1(16.6%)

4 (66.8%)

1 (16.6%)

5 (83%)

5 (83%)

IIB

27 (58.7%)

 

13 (48%)

14 (52%)

11 (41%)

14 (52%)

IIIA

12 (26.1%)

1 (8.3%)

5 (41.7%)

6 (50%)

7 (58.3%)

7 (58.3%)

IIIB

1 (2.2%)

 

1 (100%)

   
  1. Abbreviations: PD = progression disease; cPR = clinical partial response; cCR = clinical complete response; tpCR = total pathological complete response; bpCR = breast pathological complete response.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us